Bain Capital Life Sciences Investors, LLC Q1 2023 Filing

Filed May 15, 2023

Portfolio Value

$800.1B

Holdings

34

Report Date

Q1 2023

Filing Type

13F-HR

All Holdings (34 positions)

StockValue
NAMSNEWAMSTERDAM PHARMA COMPANY
$184.0M
NAMSNEWAMSTERDAM PHARMA COMPANY
$110K
NUVLNUVALENT INC
$93K
SWTXSPRINGWORKS THERAPEUTICS INC
$79K
IRONDISC MEDICINE INC
$42K
NTRANATERA INC
$38K
DVAXDYNAVAX TECHNOLOGIES CORP
$38K
CRNXCRINETICS PHARMACEUTICALS IN
$37K
MERSANA THERAPEUTICS INC
$35K
ARQTARCUTIS BIOTHERAPEUTICS INC
$33K
ACRSACLARIS THERAPEUTICS INC
$27K
PHVSPHARVARIS N V
$25K
YB4PSAVARA INC
$22K
CBAYUSDCYMABAY THERAPEUTICS INC
$21K
CTIC1USDCTI BIOPHARMA CORP
$19K
EQRX INC
$19K
ANNXANNEXON INC
$18K
NRIXNURIX THERAPEUTICS INC
$16K
TSVT*2SEVENTY BIO INC
$14K
SLDBSOLID BIOSCIENCES INC
$14K
RPIDRAPID MICRO BIOSYSTEMS INC
$11K
ASNSUSDX4 PHARMACEUTICALS INC
$10K
CARAEURCARA THERAPEUTICS INC
$10K
MRNS*MARINUS PHARMACEUTICALS INC
$9K
XLOXILIO THERAPEUTICS INC
$8K
AVIRATEA PHARMACEUTICALS INC
$8K
TNGXTANGO THERAPEUTICS INC
$7K
CCCCC4 THERAPEUTICS INC
$5K
SYRSSYROS PHARMACEUTICALS INC
$5K
NAUTNAUTILUS BIOTECHNOLOGY INC
$5K
IVVDINVIVYD INC
$2K
THRDTHIRD HARMONIC BIO INC
$2K
APTINYX INC
$1K
AGLEUSDAEGLEA BIOTHERAPEUTICS INC
$1K